Business Wire

ADVA protects critical network infrastructure with new end-to-end assured PNT solution

Share

ADVA (FSE: ADV) today announced that it has responded to calls from the US Department of Homeland Security (DHS) and National Institute of Standards and Technology (NIST) to protect critical infrastructure from the growing danger of GNSS vulnerabilities and cyber threats to positioning, navigation and timing (PNT) services with the launch of its aPNT+™ platform. This scalable solution meets all the latest guidelines for resilient PNT and is the industry’s most complete offering. It provides end-to-end control and timing network visibility for the most robust protection available against the catastrophic risks that PNT disruption poses to national security and essential assets such as power grids.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211005005061/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

ADVA’s aPNT+™ platform will prove vital in protecting critical network infrastructure (Graphic: Business Wire)

“Cyber threats are at an all-time high. At the same time, the infrastructure that our economies and lives depend on has never been more reliant on weak and highly vulnerable satellite signals. That’s why the US DHS and NIST are driving for PNT services to be more resilient and for network operators to implement strategies to counteract the vulnerabilities of GPS and other GNSS systems, including in-network PTP timing feeds. Our trusted aPNT+ platform is the definitive response. Being open and scalable, it offers an end-to-end range of cost-effective solutions and the industry’s most comprehensive features for augmented resilience, robustness and cybersecurity,” said Gil Biran, general manager, Oscilloquartz, ADVA. “For industries and governments, timing is now a critical service in need of urgent protection. Our aPNT+ platform will be the cornerstone of the most effective defense in depth strategies.”

Governments worldwide have issued guidelines to protect businesses and society from disruption to PNT services, including US Executive Order 13905, which was followed by the DHS Resilient PNT Conformance Framework and NIST Cybersecurity Framework for PNT Profile. The guidelines urge operators to swiftly implement technologies and measures to safeguard vital infrastructure. Based on these, ADVA has integrated an intelligent and scalable aPNT platform into its product portfolio. Even without GPS or GNSS timing, the solution provides an intelligent, end-to-end self-recovery system designed around a threefold framework. Integrating sophisticated multi-layer detection, multi-source backup and multi-level fault-tolerant mitigation, it delivers the highest levels of resilience, robustness and cybersecurity. This is a new standard for assured PNT services, integrating not only the DHS framework’s four levels of PNT resilience but also providing enhanced level four resilience, the highest level for trusted PNT services assurance.

“Our aPNT+ platform will be invaluable for any critical infrastructure with a crucial dependence on PNT services. With our wide-ranging product portfolio, it offers all the building blocks to create an end-to-end solution, including advanced cesium clocks, our extensive family of PTP grandmasters from core to miniature, and our innovative sync assurance application,” said Nino De Falcis, senior director, business development, Oscilloquartz, ADVA. “From transportation to national defense, from energy to finance, today’s industries need to take action against the enormous risk to lives and livelihoods that reliance on PNT represents. Now there’s a new trusted way to prevent, respond and recover PNT services against disruption with our comprehensive aPNT+ solution.”

Further details on ADVA’s aPNT+ platform can be found in this guide: https://adva.li/apnt-sync-guide.

Supporting slides can be viewed here: https://adva.li/apnt-slides.


About ADVA

ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.

About Oscilloquartz

Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to-end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA company, we’re creating new opportunities for tomorrow’s networks. For more information, please visit us at www.oscilloquartz.com.

Published by:

ADVA Optical Networking SE, Munich, Germany

www.adva.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For press:
Gareth Spence
t +44 1904 699 358
public-relations@adva.com

For investors:
Stephan Rettenberger
t +49 89 890 665 854
investor-relations@adva.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye